Medtech software entrepreneurs, mobile app and digital device developers and investors can join Bionabu’s interactive expert Q&A session to learn how to launch, certify and market their solution quickly and in line with regulations.
BIONABU – the global online medtech community where clinicians, scientists, entrepreneurs, and students can advertise their projects or ideas, communicate, consult and grow - today announces its first software as a medical device moderated Q&A discussion.
Between 1pm and 2.30pm BST on Wednesday 15th June on ZOOM, a panel of experts will answer frequently asked - and attendees’ - questions to help healthcare innovators avoid the pitfalls of the launch and certification process for software-based medical devices.
When asked about the event, Bionabu Founder and CEO Ina Burgstaller said:
“It’s all too common to hear from medtech software entrepreneurs and mobile app developers who assume they can launch their web-based solution or upload their app to the App Store or Google Play and simply wait for it to go viral.
Sadly, that’s not how it works. Software solutions need to be certified for the protection of patients, and that means trials.
MedTech entrepreneurs, software and app developers, start-ups and companies large and small often find the complex and highly regulated world of medical devices difficult to navigate.
To paraphrase Donald Rumsfeld, "we don't know what we don't know".
Many are unsure about how to tackle the critical legal, technical, clinical, and regulatory challenges when trying to bring a digital health product to market.”
The event is part of Bionabu’s commitment to nurturing emerging Medtech talent in the journey from learning to earning and spotlight innovators who have the capacity to accelerate the development of new and improved ways to alleviate human suffering and save lives.
Bionabu is on a mission to help innovators find the support they need to grow their networks and businesses and celebrate their successful innovation. It’s a project incubator in that respect.
Bionabu is in partnership on this event with d-fine, Afortiori, NanoRegMed and Johner Institut, these businesses at the cutting edge of medtech innovation.
About Bionabu (www.bionabu.com)
Bionabu is the global online medtech community where clinicians, scientists, entrepreneurs and students can advertise their projects or ideas, communicate, consult and grow.
At BIONABU we have reimagined and are building the go-to place to find a vibrant community of like-minded healthcare professionals, one that fosters novel thinking and problem-solving of clinical problems through strategic collaborations with key stakeholders in the medtech industry.
PRESS CONTACT for Bionabu
Mark Walmsley
Head of Marketing and Business Development
Email: m.walmsley@bionabu.com
Phone: +44 (0)7947 793 554